A phase 3 trial in pancreatic cancer, run by Minia University, now recruiting.
Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas is a phase 3, randomised interventional study registered as NCT07155525 by Minia University, with a registry enrolment figure of 194 participants, started 2025-09-15 and due to reach its primary completion in 2028-09-15. Interventions recorded: Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2); Standard(duct-to-mucosa) Pancreaticojejunostomy. Conditions listed: Pancreatic Cancer; Periampullary Cancer; Duodenal Cancer; Cholangiocarcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Head Mass; Bile Duct Cancer. Primary outcome: Incidence of Postoperative Pancreatic Fistula (POPF).. Pancreatic eligibility wording from the registry: "* Patients scheduled for elective pancreaticoduodenectomy for malignant lesions". Sites: Egypt. No results are recorded here; the registry entry is the source.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.